Detalles de la búsqueda
1.
Age-related trends in the incidence of metastatic colorectal cancer from 2010 to 2019 in the USA.
Future Oncol
; 2023 Sep 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-37701992
2.
Incidence of second primary malignancies in metastatic castration-resistant prostate cancer: results from observational studies in three countries.
Future Oncol
; 16(25): 1889-1901, 2020 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-32515225
3.
Baseline visual acuity as a prognostic factor for visual outcomes in patients treated with aflibercept for wet age-related macular degeneration: data from the INSIGHT study using the Swedish Macula Register.
Acta Ophthalmol
; 97(1): 91-98, 2019 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-30238648
4.
Incidence of Second Primary Malignancies in Patients with Castration-Resistant Prostate Cancer: An Observational Retrospective Cohort Study in the United States.
Prostate Cancer
; 2019: 4387415, 2019.
Artículo
en Inglés
| MEDLINE | ID: mdl-30886751
5.
Incidence of Skeletal-Related Events in Patients with Castration-Resistant Prostate Cancer: An Observational Retrospective Cohort Study in the US.
Prostate Cancer
; 2019: 5971615, 2019.
Artículo
en Inglés
| MEDLINE | ID: mdl-31360552
6.
Corrigendum to "Incidence of Second Primary Malignancies in Patients with Castration-Resistant Prostate Cancer: An Observational Retrospective Cohort Study in the United States".
Prostate Cancer
; 2019: 3425982, 2019.
Artículo
en Inglés
| MEDLINE | ID: mdl-31355002
7.
Physician and Patient Knowledge of Safety and Safe Use Information for Aflibercept in Europe: Evaluation of Risk-Minimization Measures.
Pharmaceut Med
; 33(3): 219-233, 2019 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-31933286
8.
Evaluation of Physician Knowledge of the Key Safety Information for Aflibercept in Canada: Evaluation of Risk-Minimization Measures.
Pharmaceut Med
; 33(3): 235-246, 2019 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-31933288
9.
The impact of a poison control center on the length of hospital stay for patients with poisoning.
J Toxicol Environ Health A
; 70(2): 107-10, 2007 Jan 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-17365570
10.
Poison control center surge capacity during an unusual increase in call volume--results from a natural experiment.
Prehosp Disaster Med
; 22(1): 55-8, 2007.
Artículo
en Inglés
| MEDLINE | ID: mdl-17484364
11.
Assessment of barriers to utilization of poison centers by Hispanic/Latino populations.
J Toxicol Environ Health A
; 69(18): 1711-8, 2006 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-16864421
12.
Seasonal changes in poisoning exposures reported to a regional poison center from coastal resort areas.
J Toxicol Environ Health A
; 68(5): 315-8, 2005 Mar 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-15799624
13.
Assessment of the utilization of a state AIDS/STD hotline by persons with and without HIV infection and their information needs.
AIDS Patient Care STDS
; 19(10): 684-9, 2005 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-16232052
14.
Case of elevated blood lead in a South Asian family that has used Sindoor for food coloring.
Clin Toxicol (Phila)
; 43(4): 301-3, 2005.
Artículo
en Inglés
| MEDLINE | ID: mdl-16035209
15.
Diabetes, cardiovascular morbidity, and risk of age-related macular degeneration in a primary care population.
Invest Ophthalmol Vis Sci
; 56(3): 1585-92, 2015 Feb 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-25670489
16.
Rapid communication: sociodemographic differences between counties with high and low utilization of a regional poison control center.
J Toxicol Environ Health A
; 66(20): 1905-8, 2003 Oct 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-14514432
17.
On-site HIV testing in residential drug treatment units: results of a nationwide survey.
Public Health Rep
; 118(1): 37-43, 2003.
Artículo
en Inglés
| MEDLINE | ID: mdl-12604763
18.
Gaps in the drug-free and methadone treatment program response to Hepatitis C.
J Subst Abuse Treat
; 24(4): 291-7, 2003 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-12867202
19.
Injection drug users and the provision of hepatitis C-related services in a nationwide sample of drug treatment programs.
J Behav Health Serv Res
; 31(2): 208-16, 2004.
Artículo
en Inglés
| MEDLINE | ID: mdl-15255228
20.
Provision of on-site medical care to patients with hepatitis C in drug treatment units.
J Health Care Poor Underserved
; 15(4): 663-71, 2004 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-15531822